COVID-19

In February 2023, we responded to this inquiry, with feedback from members in Scotland. Unlike some parts of the UK, Scotland does not have a specific service aimed at long COVID, nor one focussed on children and young people with chronic fatigue and pain. Read a short summary of our response and re...

Following recent observations of a sustained rise in rates of infections of Respiratory Syncytial Virus (RSV), it has been recommended that the palivizumab passive immunisation programme recommences.

Since March 2020 the COVID-19 pandemic has caused unprecedented disruption to training and assessment in paediatrics in the UK as well as significant stresses to everyone's working and personal lives. We hope that, two years on, we are beginning to return to normal or at least to readjust to a new n...